Immunoassay Market Research Report - Forecast till 2027

Immunoassay Market Research Report: by Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Technology [Radioimmunoassay (RIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others], Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) and Region - Forecast till 2027

ID: MRFR/HC/4385-HCR | February 2021 | Region: Global | 90 pages

Immunoassay Market overview


The Immunoassay market value was USD 18,626.7 million in 2018, and it is expected to grow at a CAGR rate of 5.9% in the forecast period (2019-2025). Immunoassay is a method of detecting or measuring a specific type of protein. The market uses different types of antibody-antigen reactions to detect the biological substance in the fluid and blood. Immunoassay test uses binding of antibodies to confirm the presence of certain types of substances, and it is highly used to detect diseases. Immunoassay also provides the detail about the disease that help to plan the treatment procedure, for instance, the detection of estrogen receptors in breast cancer, and it can be applied in various formats depending on the requirements. 


The major job of Immunoassay is to measure the presence of chemical constituents. Technological advancement has led to easy application of Immunoassay, and it is boosting the Immunoassay market growth. Immunoassay plays a huge role in clinical diagnostics, environmental monitoring, and pharmaceutical analysis. It is wildly used in research centers, laboratories, hospitals to detect different diseases and come up with an effective treatment plan for both humans and animals. Additionally, this method is fast and cost-effective. Due to the wide range of applications, the market is growing rapidly, and the market size is increasing. Apart from that, the rapid growth in the individual suffering from the chronic disease propelling the Immunoassay industry growth.


The rising demand for advanced devices and the increasing adoption of these devices have a positive influence on the Immunoassay industry. The availability of sensitive diagnostics tests is also fueling the Immunoassay market trends. Increasing focus on private and public initiatives and increasing demand for cost-effective drugs will boost the market in the coming years. Apart from the growing prevalence of diseases such as HIV, dengue, hepatitis will have a good impact on the market growth. 


Covid-19 analysis


Due to the coronavirus outbreak, the world is going through a financial crisis. The covid-19 had a negative impact on the global economy as well and other businesses around the world. The government took several safety measures such as lockdown and social distancing guidelines to reduce the spread of the virus. However, it had a negative impact on the economic growth of the countries. But the Immunoassay product played a huge role in reducing the spread of the virus without the vaccine or medicines. The Immunoassay was the only method to control and manage the rapid spread of the virus. There is huge demand and use of Immunoassay can be seen during the period. Due to this, the Immunoassay market demand has increased a lot in the countries. But due to travel restrictions and the lockdown, the supply chain was highly affected. There are many rules imposed by the government bodies in several countries; due to the lack of supply of Immunoassay and the disruption in the supply chain, there was a negative impact on the market. So, overall, the market had a moderate growth due to the covid-19 pandemic.


Immunoassay Market Share (%), by Region, 2018  Immunoassay Market_Image


Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis


Market dynamics



  • Drivers


There are many factors that are responsible for driving the Immunoassay market. One of the major drivers in the market is the rising chronic diseases, diabetes diseases, and cardiovascular diseases. Apart from that prevalence of infections such as covid-19, dengue, hepatitis, HIV, Malaria, and other diseases is propelling the Immunoassay industry demand. According to the world health organization (WHO), 19,655,3009 have tested positive for the covid-19 to date. As a result, the use of Immunoassay has increased in recent times. The Immunoassay test is cost-effective and offering expedited results with detection limits, higher efficiency, and it is one of the major drivers in the Immunoassay industry. ELISA is a widely used Immunoassay method to detect infectious diseases, and this method is to measure antigens, antibodies, proteins in samples. With the development of signal generation methods, the focus has shifted on the development of the many instruments to offer convenient and high performance. And it is driving the Immunoassay industry.



  • Opportunities


Immunoassay is widely sued for various applications such as pharmaceutical analysis, food safety, medical diagnostics, and basic science investigations. Usage of Immunoassay in a wide range of areas will bring opportunities to the Immunoassay market. The rising demand for safer drugs and specialist therapies across the world is generating opportunities for the market. Developing counties like Asia-pacific are expected to offer significant growth opportunities for the market. 


Apart from that, the rapid growth of the population in the Asian region and will drive the need for Immunoassay tests. All these factors will bring opportunities to the market, and the Immunoassay market will grow higher in the forecast period.



  • Restraints


The government and the regulatory authorities in several nations have imposed regulation on the commercialization and of the Immunoassay instrument and consumables. It has become and a big challenge for the Immunoassay market. Apart from that, technological hurdles imposed by the Immunoassay reagents and kits, such as low detection limits of the available antibodies, cross-reactivity of the antibodies, and false results, will hamper the Immunoassay industry.



  • Challenges


There are many challenges faced by the Immunoassay market, just like another market. One of the major challenges is the design challenge associated with the Immunoassay. Due to design, the misinterpretation of the results can happen. Also, the lack of skilled professionals in the diagnostics domain is a big challenge for the market. The key players are trying their best to overcome these challenges and boost the Immunoassay industry demand.


Cumulative growth analysis


With the wide range of applications of Immunoassay in various areas, the Immunoassay industry will show rapid growth in the forecast period. The market is expected to register to a healthy CAGR of 5.9% in the Immunoassay market forecast period. 


Market segmentation


The Immunoassay market is segmented on the basis of product, specimen, application, technology, and end-user


By product


On the basis of product, the market is divided into reagents and kits, and analyzers. Regents and kits are further carried out into ELISPOT Reagents & Kits ELISA Reagents & Kits, Western Blot Reagents & Kits Rapid Test Reagents & Kits, and others. Analyzers include Open-Ended Systems and Closed-Ended Systems. Reagents and Kits hold a huge Immunoassay market share.


By specimen


On the basis of the specimen, the Immunoassay industry is divided into Blood, Saliva, Urine, and others. The Immunoassay involves the use of fluid and blood to check the presence of antibodies. 


By application


On the basis of application, the Immunoassay industry is segmented into Endocrinology, Oncology, Cardiology, Blood Screening, Toxicology, Newborn Screening, Infectious Diseases, Autoimmune Disorders, Allergy Diagnostics, Bone & Mineral Disorders, and Others. The infectious disease was accounted for the highest Immunoassay industry share with 25% in 2020. 


By technology


On the basis of technology, the Immunoassay industry is segmented into Western Blotting, Enzyme-Linked Immunospot, ELISA, Rapid Tests, Radio-Immuno Assay, and Other Technologies. ELISA segment was accounted for the highest Immunoassay industry with 60%.


By end-user 


The end-user segment of the market is divided into Blood Banks, Research & Academic Laboratories, Home Care Settings Hospitals and Clinics, Pharmaceutical and Biotechnology Companies & CROs, and Clinical Laboratories. The hospital segment was responsible for the largest share, over 30%, in the year 2020.


Regional analysis


The major regions in the Immunoassay industry are America, Europe, Asia-pacific, and Middle East & Africa. America held the highest Immunoassay market share in 2018 due to the contribution of government funds, increasing the number of research projects, and the increasing adoption of Immunoassay in this region. Europe holds the second-highest share in the Immunoassay industry due to the presence of big companies. Asia-pacific is expected to witness rapid growth due to the rising geriatric population. The market in the middle east & Africa will see moderate growth due to the growth of the healthcare sector in this region. 


Competitive landscape


The major key players in the Immunoassay market are:



  • Siemens Healthineers, 

  • Abbott Laboratories, 

  • Becton Merck KGaA, 

  • Sysmex Corporation, 

  • Ortho-Clinical Diagnostics/Carlyle Group,

  • Dickinson and Company, 

  • Danaher Corporation, 

  • Thermo Fisher Scientific Inc.,

  • Hoffmann-La Roche Ltd, 

  • bioMérieux SA,Quidel Corporation, 

  • DiaSorin S.p. A.


Recent developments 



  • In February 2021, Thermo Fisher Scientific Inc. acquired Mesa Biotech which is the private point- of care molecular diagnostic company.


Report overview


This Immunoassay Market report is based on the qualitative and quantitative analysis of the Immunoassay industry. This report highlights the Immunoassay industry outlook on the market overviews, covid-19 analysis, market dynamics, and Immunoassay industry analysis. This Immunoassay industry also shows the regional analysis, competitive landscape, and recent development of the market.


Segmental table


By product 



  • Reagents and Kits

  • Analyzers/Instruments

  • Software and Services


By specimen



  • Blood

  • Saliva

  • Urine

  • Others


By technology



  • Radioimmunoassay (RIA)

  • Enzyme-linked Immunosorbent Assay (ELISA)

  • Enzyme-linked Fluorescent Assay (ELFA)

  • Chemiluminescence Immunoassay (CLIA)

  • Rapid Test

  • Others 


By application



  • Therapeutic Drug Monitoring



  • Oncology



  • Cardiology



  • Endocrinology



  • Infectious Diseases



  • Autoimmune Diseases



  • Others


By end-user



  • Hospitals



  • Clinical Laboratories



  • Blood Banks



  • Pharmaceutical and Biotechnology Companies



  • Academic and Research Institutes



  • Others



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 18,626.7 Million (2025)
  CAGR   5.9% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Indication, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.P.A.
  Key Market Opportunities   Increasing Adoption of immunoassay-based point-of-care (POC) testing and rapid testing
  Key Market Drivers   The Rising prevalence of chronic and infectious diseases


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Immunoassay Market was valued at over USD 18.6 billion in 2018.

Immunoassay Market is expected to exhibit a strong 5.9% CAGR over the forecast period from 2019 to 2025.

Immunoassays are used to detect the concentration of a wide range of biological substances in blood.

The rising prevalence of chronic and infectious diseases is the major driver for the global immunoassay market.

Lack of support from reimbursement agencies and strict regulatory requirements are the major restraint on the global immunoassay market.

Table of Contents


Chapter 1 Executive Summary

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Assumptions and Limitations

2.4 Market Structure

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Immunoassay Market, by Product

6.1 Introduction

6.2 Reagents and Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Analyzers/Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Software and Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7 Global Immunoassay Market, by Technology

7.1 Introduction

7.2 Radioimmunoassay (RIA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Enzyme-linked Immunosorbent Assay (ELISA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Enzyme-linked Fluorescent Assay (ELFA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Chemiluminescence Immunoassay (CLIA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Rapid Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8 Global Immunoassay Market, by Indication

8.1 Introduction

8.2 Therapeutic Drug Monitoring

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Oncology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Cardiology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Endocrinology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Infectious Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Autoimmune Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.8 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9 Global Immunoassay Market, by End User

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Clinical Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Blood Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.6 Academic and Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10 Global Immunoassay Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Developments & Strategies

Chapter 12 Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategies

12.2 F. Hoffmann-La Roche Ltd

12.3 Siemens Healthineers

12.4 bioMérieux SA

12.5 Becton, Dickinson and Company

12.6 Danaher Corporation

12.7 Abbott Laboratories

12.8 Merck KGaA

12.9 Sysmex Corporation

12.10 Ortho Clinical Diagnostics/Carlyle Group

12.11 Quidel Corporation

12.12 DiaSorin S.p.A.

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Immunoassay Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Immunoassay Market Synopsis, 2020-2027

Table 2 Global Immunoassay Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Immunoassay Market, by Region, 2020-2027 (USD Million)

Table 4 Global Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 5 Global Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 6 Global Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 7 Global Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 8 North America: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 10 North America Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 11 North America Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 12 US: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 13 US: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 14 US Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 15 US Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 16 Canada: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 17 Canada: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 18 Canada Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 19 Canada Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 20 Latin America: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 21 Latin America: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 22 Latin America Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 23 Latin America Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 24 Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 26 Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 27 Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 28 Western Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 29 Western Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 30 Western Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 31 Western Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 32 Eastern Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 33 Eastern Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 34 Eastern Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 35 Eastern Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 38 Asia-Pacific Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 39 Asia-Pacific Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 42 Middle East & Africa Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 43 Middle East & Africa Immunoassay Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunoassay Market

Figure 3 Segmentation Market Dynamics for Global Immunoassay Market

Figure 4 Global Immunoassay Market Share, by Product, 2020

Figure 5 Global Immunoassay Market Share, by Technology, 2020

Figure 6 Global Immunoassay Market Share, by Indication, 2020

Figure 7 Global Immunoassay Market Share, by End User, 2020

Figure 8 Global Immunoassay Market Share, by Region, 2020

Figure 9 North America: Immunoassay Market Share, by Country, 2020

Figure 10 Europe: Immunoassay Market Share, by Country, 2020

Figure 11 Asia-Pacific: Immunoassay Market Share, by Country, 2020

Figure 12 Middle East & Africa: Immunoassay Market Share, by Country, 2020

Figure 13 Global Immunoassay Market: Company Share Analysis, 2020 (%)

Figure 14 Thermo Fisher Scientific Inc.: Key Financials

Figure 15 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 16 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 17 F. Hoffmann-La Roche Ltd: Key Financials

Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 20 Siemens Healthineers: Key Financials

Figure 21 Siemens Healthineers: Segmental Revenue

Figure 22 Siemens Healthineers: Geographical Revenue

Figure 23 bioMérieux SA: Key Financials

Figure 24 bioMérieux SA: Segmental Revenue

Figure 25 bioMérieux SA: Geographical Revenue

Figure 26 Becton, Dickinson and Company: Key Financials

Figure 27 Becton, Dickinson and Company: Segmental Revenue

Figure 28 Becton, Dickinson and Company: Geographical Revenue

Figure 29 Danaher Corporation: Key Financials

Figure 30 Danaher Corporation: Segmental Revenue

Figure 31 Danaher Corporation: Geographical Revenue

Figure 32 Abbott Laboratories: Key Financials

Figure 33 Abbott Laboratories: Segmental Revenue

Figure 34 Abbott Laboratories: Geographical Revenue

Figure 35 Merck KGaA: Key Financials

Figure 36 Merck KGaA: Segmental Revenue

Figure 37 Merck KGaA: Geographical Revenue

Figure 38 Sysmex Corporation: Key Financials

Figure 39 Sysmex Corporation: Segmental Revenue

Figure 40 Sysmex Corporation: Geographical Revenue

Figure 41 Ortho Clinical Diagnostics/Carlyle Group: Key Financials

Figure 42 Ortho Clinical Diagnostics/Carlyle Group: Segmental Revenue

Figure 43 Ortho Clinical Diagnostics/Carlyle Group: Geographical Revenue

Figure 44 Quidel Corporation: Key Financials

Figure 45 Quidel Corporation: Segmental Revenue

Figure 46 Quidel Corporation: Geographical Revenue

Figure 47 DiaSorin S.p.A.: Key Financials

Figure 48 DiaSorin S.p.A.: Segmental Revenue

Figure 49 DiaSorin S.p.A.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.